{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:31:35Z","timestamp":1777354295903,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6948","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1038\/nature01850","type":"journal-article","created":{"date-parts":[[2003,7,21]],"date-time":"2003-07-21T09:02:58Z","timestamp":1058778178000},"page":"516-523","source":"Crossref","is-referenced-by-count":740,"title":["Integration of interferon-\u03b1\/\u03b2 signalling to p53 responses in tumour suppression and antiviral defence"],"prefix":"10.1038","volume":"424","author":[{"given":"Akinori","family":"Takaoka","sequence":"first","affiliation":[]},{"given":"Sumio","family":"Hayakawa","sequence":"additional","affiliation":[]},{"given":"Hideyuki","family":"Yanai","sequence":"additional","affiliation":[]},{"given":"Dagmar","family":"Stoiber","sequence":"additional","affiliation":[]},{"given":"Hideo","family":"Negishi","sequence":"additional","affiliation":[]},{"given":"Hideaki","family":"Kikuchi","sequence":"additional","affiliation":[]},{"given":"Shigeru","family":"Sasaki","sequence":"additional","affiliation":[]},{"given":"Kohzoh","family":"Imai","sequence":"additional","affiliation":[]},{"given":"Tsukasa","family":"Shibue","sequence":"additional","affiliation":[]},{"given":"Kenya","family":"Honda","sequence":"additional","affiliation":[]},{"given":"Tadatsugu","family":"Taniguchi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2003,7,16]]},"reference":[{"key":"BFnature01850_CR1","first-page":"221","volume":"5","author":"M Oren","year":"1994","unstructured":"Oren, M. Relationship of p53 to the control of apoptotic cell death. Semin. Cancer Biol. 5, 221\u2013227 (1994)","journal-title":"Semin. Cancer Biol."},{"key":"BFnature01850_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/381643a0","volume":"381","author":"T Jacks","year":"1996","unstructured":"Jacks, T. & Weinberg, R. A. Cell-cycle control and its watchman. Nature 381, 643\u2013644 (1996)","journal-title":"Nature"},{"key":"BFnature01850_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3","volume":"187","author":"C Prives","year":"1999","unstructured":"Prives, C. & Hall, P. A. The p53 pathway. J. Pathol. 187, 112\u2013126 (1999)","journal-title":"J. Pathol."},{"key":"BFnature01850_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307\u2013310 (2000)","journal-title":"Nature"},{"key":"BFnature01850_CR5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrc864","volume":"2","author":"KH Vousden","year":"2002","unstructured":"Vousden, K. H. & Lu, X. Live or let die: the cell's response to p53. Nature Rev. Cancer 2, 594\u2013604 (2002)","journal-title":"Nature Rev. Cancer"},{"key":"BFnature01850_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","volume":"56","author":"S Pestka","year":"1987","unstructured":"Pestka, S., Langer, J. A., Zoon, K. C. & Samuel, C. E. Interferons and their actions. Annu. Rev. Biochem. 56, 727\u2013777 (1987)","journal-title":"Annu. Rev. Biochem."},{"key":"BFnature01850_CR7","volume-title":"Interferons and Other Regulatory Cytokines","author":"E De Maeyer","year":"1988","unstructured":"De Maeyer, E. & De Maeyer-Guignard, J. Interferons and Other Regulatory Cytokines (John Wiley and Sons, New York, 1988)"},{"key":"BFnature01850_CR8","first-page":"375","volume-title":"Fields Virology","author":"J Vilcek","year":"1996","unstructured":"Vilcek, J. & Sen, G. S. in Fields Virology 3rd edn (eds Fields, D. M., Knipe, P. M. & Howley, P. M.) 375\u2013399 (Lippincott-Raven, Philadelphia, 1996)"},{"key":"BFnature01850_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1074-7613(01)00154-6","volume":"14","author":"CA Biron","year":"2001","unstructured":"Biron, C. A. Interferons \u03b1 and \u03b2 as immune regulators\u2014a new look. Immunity 14, 661\u2013664 (2001)","journal-title":"Immunity"},{"key":"BFnature01850_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S1359-6101(01)00035-1","volume":"13","author":"I Gresser","year":"2002","unstructured":"Gresser, I. & Belardelli, F. Endogenous type I interferons as a defense against tumors. Cytokine Growth Factor Rev. 13, 111\u2013118 (2002)","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnature01850_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF01877207","volume":"8","author":"H Strander","year":"1996","unstructured":"Strander, H. & Einhorn, S. Interferons and the tumor cell. Biotherapy 8, 213\u2013218 (1996)","journal-title":"Biotherapy"},{"key":"BFnature01850_CR12","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1073\/pnas.91.4.1198","volume":"91","author":"JU Gutterman","year":"1994","unstructured":"Gutterman, J. U. Cytokine therapeutics: lessons from interferon \u03b1. Proc. Natl Acad. Sci. USA 91, 1198\u20131205 (1994)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature01850_CR13","first-page":"2489","volume":"58","author":"LM Pfeffer","year":"1998","unstructured":"Pfeffer, L. M. et al. Biological properties of recombinant \u03b1-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58, 2489\u20132499 (1998)","journal-title":"Cancer Res."},{"key":"BFnature01850_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/carcin\/14.5.987","volume":"14","author":"IC Hsu","year":"1993","unstructured":"Hsu, I. C. et al. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 14, 987\u2013992 (1993)","journal-title":"Carcinogenesis"},{"key":"BFnature01850_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0","volume":"387","author":"Y Haupt","year":"1997","unstructured":"Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296\u2013299 (1997)","journal-title":"Nature"},{"key":"BFnature01850_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/387299a0","volume":"387","author":"MH Kubbutat","year":"1997","unstructured":"Kubbutat, M. H., Jones, S. N. & Vousden, K. H. Regulation of p53 stability by Mdm2. Nature 387, 299\u2013303 (1997)","journal-title":"Nature"},{"key":"BFnature01850_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0959-437X(99)00038-6","volume":"10","author":"CJ Sherr","year":"2000","unstructured":"Sherr, C. J. & Weber, J. D. The ARF\/p53 pathway. Curr. Opin. Genet. Dev. 10, 94\u201399 (2000)","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFnature01850_CR18","first-page":"1285","volume":"5","author":"D Ginsberg","year":"1990","unstructured":"Ginsberg, D., Oren, M., Yaniv, M. & Piette, J. Protein-binding elements in the promoter region of the mouse p53 gene. Oncogene 5, 1285\u20131290 (1990)","journal-title":"Oncogene"},{"key":"BFnature01850_CR19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell Jr","year":"1994","unstructured":"Darnell, J. E. Jr, Kerr, I. M. & Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415\u20131421 (1994)","journal-title":"Science"},{"key":"BFnature01850_CR20","doi-asserted-by":"crossref","first-page":"19523","DOI":"10.1016\/S0021-9258(17)32200-7","volume":"269","author":"SJ Haque","year":"1994","unstructured":"Haque, S. J. & Williams, B. R. Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-\u03b1. J. Biol. Chem. 269, 19523\u201319529 (1994)","journal-title":"J. Biol. Chem."},{"key":"BFnature01850_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/1359-6101(96)00005-6","volume":"7","author":"AR Bluyssen","year":"1996","unstructured":"Bluyssen, A. R., Durbin, J. E. & Levy, D. E. ISGF3\u03b3 p48, a specificity switch for interferon activated transcription factors. Cytokine Growth Factor Rev. 7, 11\u201317 (1996)","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnature01850_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","volume":"75","author":"M Scheffner","year":"1993","unstructured":"Scheffner, M., Huibregtse, J. M., Vierstra, R. D. & Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495\u2013505 (1993)","journal-title":"Cell"},{"key":"BFnature01850_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev. Cancer 2, 342\u2013350 (2002)","journal-title":"Nature Rev. Cancer"},{"key":"BFnature01850_CR24","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1128\/JVI.75.9.4467-4472.2001","volume":"75","author":"T Veldman","year":"2001","unstructured":"Veldman, T., Horikawa, I., Barrett, J. C. & Schlegel, R. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J. Virol. 75, 4467\u20134472 (2001)","journal-title":"J. Virol."},{"key":"BFnature01850_CR25","first-page":"3313","volume":"8","author":"T Tsukada","year":"1993","unstructured":"Tsukada, T. et al. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8, 3313\u20133322 (1993)","journal-title":"Oncogene"},{"key":"BFnature01850_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","volume":"74","author":"SW Lowe","year":"1993","unstructured":"Lowe, S. W., Ruley, H. E., Jacks, T. & Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957\u2013967 (1993)","journal-title":"Cell"},{"key":"BFnature01850_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1172\/JCI6863","volume":"104","author":"F Bunz","year":"1999","unstructured":"Bunz, F. et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104, 263\u2013269 (1999)","journal-title":"J. Clin. Invest."},{"key":"BFnature01850_CR28","first-page":"927","volume":"10","author":"K Butz","year":"1995","unstructured":"Butz, K. et al. Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10, 927\u2013936 (1995)","journal-title":"Oncogene"},{"key":"BFnature01850_CR29","first-page":"3972","volume":"59","author":"MS Mendonca","year":"1999","unstructured":"Mendonca, M. S. et al. Delayed apoptotic responses associated with radiation-induced neoplastic transformation of human hybrid cells. Cancer Res. 59, 3972\u20133979 (1999)","journal-title":"Cancer Res."},{"key":"BFnature01850_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0966-842X(96)10083-4","volume":"5","author":"JC Neil","year":"1997","unstructured":"Neil, J. C., Cameron, E. R. & Baxter, E. W. p53 and tumour viruses: catching the guardian off-guard. Trends Microbiol. 5, 115\u2013120 (1997)","journal-title":"Trends Microbiol."},{"key":"BFnature01850_CR31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.281.5381.1317","volume":"281","author":"G Evan","year":"1998","unstructured":"Evan, G. & Littlewood, T. A matter of life and cell death. Science 281, 1317\u20131322 (1998)","journal-title":"Science"},{"key":"BFnature01850_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1359-6101(00)00027-7","volume":"12","author":"DE Levy","year":"2001","unstructured":"Levy, D. E. & Garcia-Sastre, A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev. 12, 143\u2013156 (2001)","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnature01850_CR33","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","volume":"81","author":"S Goodbourn","year":"2000","unstructured":"Goodbourn, S., Didcock, L. & Randall, R. E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81, 2341\u20132364 (2000)","journal-title":"J. Gen. Virol."},{"key":"BFnature01850_CR34","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri888","volume":"2","author":"MG Katze","year":"2002","unstructured":"Katze, M. G., He, Y. & Gale, M. Jr Viruses and interferon: a fight for supremacy. Nature Rev. Immunol. 2, 675\u2013687 (2002)","journal-title":"Nature Rev. Immunol."},{"key":"BFnature01850_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/356215a0","volume":"356","author":"LA Donehower","year":"1992","unstructured":"Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215\u2013221 (1992)","journal-title":"Nature"},{"key":"BFnature01850_CR36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","volume":"91","author":"SY Shieh","year":"1997","unstructured":"Shieh, S. Y., Ikeda, M., Taya, Y. & Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325\u2013334 (1997)","journal-title":"Cell"},{"key":"BFnature01850_CR37","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1126\/science.281.5383.1674","volume":"281","author":"S Banin","year":"1998","unstructured":"Banin, S. et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674\u20131677 (1998)","journal-title":"Science"},{"key":"BFnature01850_CR38","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1126\/science.281.5383.1677","volume":"281","author":"CE Canman","year":"1998","unstructured":"Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677\u20131679 (1998)","journal-title":"Science"},{"key":"BFnature01850_CR39","first-page":"1664","volume":"57","author":"CH Westphal","year":"1997","unstructured":"Westphal, C. H. et al. Genetic interactions between ATM and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res. 57, 1664\u20131667 (1997)","journal-title":"Cancer Res."},{"key":"BFnature01850_CR40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499\u2013506 (2003)","journal-title":"Nature"},{"key":"BFnature01850_CR41","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","volume":"288","author":"E Oda","year":"2000","unstructured":"Oda, E. et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053\u20131058 (2000)","journal-title":"Science"},{"key":"BFnature01850_CR42","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1101\/gad.10.15.1945","volume":"10","author":"K Polyak","year":"1996","unstructured":"Polyak, K., Waldman, T., He, T. C., Kinzler, K. W. & Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945\u20131952 (1996)","journal-title":"Genes Dev."},{"key":"BFnature01850_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1359-6101(00)00023-X","volume":"12","author":"AE Koromilas","year":"2001","unstructured":"Koromilas, A. E., Li, S. & Matlashewski, G. Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev. 12, 157\u2013170 (2001)","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnature01850_CR44","first-page":"3473","volume":"50","author":"S Wadler","year":"1990","unstructured":"Wadler, S. & Schwartz, E. L. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res. 50, 3473\u20133486 (1990)","journal-title":"Cancer Res."},{"key":"BFnature01850_CR45","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1046\/j.1440-1746.2000.02289.x","volume":"15","author":"A Miyamoto","year":"2000","unstructured":"Miyamoto, A. et al. Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of \u03b1-interferon and oral tegafur\/uracil. J. Gastroenterol. Hepatol. 15, 1447\u20131451 (2000)","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnature01850_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1046\/j.1365-2443.1996.08008.x","volume":"1","author":"T Kimura","year":"1996","unstructured":"Kimura, T. et al. Essential and non-redundant roles of p48 (ISGF3\u03b3) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells 1, 115\u2013124 (1996)","journal-title":"Genes Cells"},{"key":"BFnature01850_CR47","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1126\/science.288.5475.2357","volume":"288","author":"A Takaoka","year":"2000","unstructured":"Takaoka, A. et al. Cross talk between interferon-\u03b3 and -\u03b1\/\u03b2 signaling components in caveolar membrane domains. Science 288, 2357\u20132360 (2000)","journal-title":"Science"},{"key":"BFnature01850_CR48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1074-7613(00)00053-4","volume":"13","author":"M Sato","year":"2000","unstructured":"Sato, M. et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-\u03b1\/\u03b2 gene induction. Immunity 13, 539\u2013548 (2000)","journal-title":"Immunity"},{"key":"BFnature01850_CR49","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/0092-8674(94)90132-5","volume":"77","author":"N Tanaka","year":"1994","unstructured":"Tanaka, N. et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77, 829\u2013839 (1994)","journal-title":"Cell"},{"key":"BFnature01850_CR50","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0092-8674(85)80022-2","volume":"41","author":"T Fujita","year":"1985","unstructured":"Fujita, T., Ohno, S., Yasumitsu, H. & Taniguchi, T. Delimitation and properties of DNA sequences required for the regulated expression of human interferon-\u03b2 gene. Cell 41, 489\u2013496 (1985)","journal-title":"Cell"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature01850.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature01850","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature01850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature01850.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:16:38Z","timestamp":1684419398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature01850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":50,"journal-issue":{"issue":"6948","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["BFnature01850"],"URL":"https:\/\/doi.org\/10.1038\/nature01850","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1015334.196752","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1015334.196457","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}